Intranasal Peptide Delivery: Nasal Mucosal Barriers, Permeability and Pharmacokinetic Research

Intranasal Peptide Delivery and Nasal Mucosal Biology

Research into intranasal peptides looks at the way peptide molecules interact with the nasal cavity and whether the nasal environment can allow for measurable transport across the mucosal barrier. Different from oral delivery research in which gastrointestinal degradation and intestinal absorption are the main factors, nasal studies concentrate on epithelial permeability, enzymatic activity, mucociliary clearance, peptide stability and deposition in various areas of the nasal cavity.

Although the nasal mucosa is very well supplied with blood vessels, the presence of blood vessels by itself does not decide whether a peptide will be able to pass through the epithelial barrier. Factors such as molecular size, hydrophilicity, charge, structural stability and the characteristics of the formulation can all affect transport. Reviews that have been published indicate that nasal peptide delivery is a technically difficult field since peptides generally have limited ability to penetrate and may be subject to enzymatic degradation before they reach the systemic circulation.

From a research point of view, intranasal peptide delivery involves more than just determining whether a compound can be included in a nasal formulation; the key scientific issue is how the molecular properties of a specific peptide interact with the biological and physical conditions of the nasal cavity.

Why the Nasal Mucosa Matters in Peptide Research

The nasal cavity has distinct areas of epithelium which are biologically different. The respiratory epithelium covers a large part of the nasal cavity and plays a significant role in mucosal absorption and clearance. The olfactory region, on the other hand, has a different arrangement of cells and is therefore of particular importance in research into possible transport between the nasal cavity and the central nervous system.

The epithelial barrier has tight junctions and cellular membranes which limit the movement of most macromolecules, and since peptides are usually hydrophilic and bigger than many ordinary small-molecule compounds this reduces their passive membrane permeability.

Research therefore examines the relationship between the physicochemical properties of peptides and epithelial transport, since molecular weight, polarity, solubility and structural conformation can affect the proportion of the material that remains at the mucosal surface and the proportion that passes through the epithelial barrier.

A review carried out in 2018 looked at the variables relating to intranasal peptide development and found that molecular weight, solubility, formulation characteristics, pH, osmolality, deposition, and nasal saturation capacity were among the relevant factors. The review also stated that peptides up to about 6,000 Da have been studied in research into intranasal delivery, even though molecular size is only one part of the overall delivery performance.

Peptide Stability in the Nasal Environment

Since peptide stability is an important experimental variable, the peptide has to keep enough of its structural integrity throughout the period of evaluation.

The nasal cavity is not an inert surface. Enzymatic activity within the nasal mucosa can contribute to peptide degradation, while mucus and mucociliary transport can reduce the time that a molecule remains in contact with the epithelial surface.

There is thus a significant difference between the amount of peptide put into a formulation and the amount of peptide that remains structurally intact and is therefore capable of being absorbed.

Analytical studies can become especially important in the interpretation of experiments involving intranasal peptides. Methods like high-performance liquid chromatography and mass spectrometry may be employed to investigate the identity, purity and degradation products of the peptides. It would be difficult to assign changes in the biological measurements specifically to the intact peptide in the absence of suitable analytical controls.

Structure is also important. Peptides which have been modified, have alterations at their terminals or involve substitutions in their sequence may act differently from those that are unmodified. It therefore follows that research carried out on one peptide should not be automatically applied to another substance just because both are peptides.

Mucociliary Clearance and Nasal Residence Time

Mucociliary clearance is another major variable in nasal peptide research.

The mucus is constantly transported by the nasal epithelium towards the nasopharynx. This protective mechanism aids in the removal of particles and foreign material from the nasal cavity, but it may also decrease the length of time that a peptide formulation remains on the epithelial surface.

Since the residence time is short, it becomes difficult for epithelial transport to take place. To this end, researchers examine the formulation characteristics that affect how long the compound remains associated with the nasal mucosa.

This area of research involves mucoadhesive systems, particulate carriers, gels and other methods of formulation. The reasons for investigating these technologies are that they are able to alter residence time, local distribution or provide molecular protection. Yet the performance of these systems still depends on the properties of the peptide and the formulation under study.

Mucociliary clearance also introduces variability between experimental systems. Differences in mucus composition, epithelial condition and species can affect the interpretation of absorption studies.

Molecular Size and Nasal Permeability

Molecular size is one of the variables that is most often discussed in the context of intranasal peptide delivery.

Small peptides may differ in their transport properties from larger proteins or peptide complexes. Yet molecular weight should not be regarded as the only factor that can predict permeability since charge, hydrophilicity, conformation, solubility and interaction with the mucosal environment also play a role.

A review carried out in 2009 on the nasal delivery of high molecular weight substances stated that peptide and protein molecules generally have low nasal bioavailability due to their hydrophilic character, limited ability to penetrate the mucous membrane, enzymatic degradation, and mucociliary clearance.

It is for this reason that research into intranasal peptides usually concentrates on formulation and molecular engineering rather than just altering the method of delivery.

It is important when carrying out experimental comparisons to clearly define molecular identity. Peptides which have similar molecular weights may still show quite different physicochemical behaviour since their amino acid sequences, modifications and three-dimensional structures are different.

Systemic Absorption and Nose-to-Brain Research Are Different Questions

Intranasal peptide studies are sometimes referred to as "nose-to-brain" research, but systemic absorption and direct transport to the central nervous system are separate issues studied in different experiments.

A peptide which is deposited in the nasal cavity can enter the systemic circulation via the nasal mucosa. This is one possible route by which measurable exposure might occur.

There is another area of research which looks into whether materials can get to the central nervous system via the olfactory and trigeminal areas. The experimental literature has suggested a number of mechanisms involving neural pathways, the perivascular spaces, cerebrospinal fluid and vascular transport.

Just because there are these anatomical pathways does not prove that each peptide studied by the intranasal route gets to the brain via direct transport. To show that a true nose-to-brain pathway exists, suitable experimental controls and measurements are needed in order to tell the direct transport apart from exposure through the systemic circulation and then secondary distribution.

The latest reviews still point out uncertainty as to the relative contribution of the olfactory, trigeminal and systemic pathways, and differences between species in terms of nasal anatomy and epithelial biology also make it difficult to translate findings from animal models to other experimental systems.

Pharmacokinetic Research After Intranasal Peptide Exposure

Pharmacokinetics provides another way to evaluate peptide transport.

Researchers may examine plasma concentration over time, exposure profiles, apparent bioavailability and the relationship between molecular stability and measurable systemic levels. For CNS-focused studies, researchers may additionally examine peptide or peptide-derived material in brain tissue, cerebrospinal fluid or other relevant compartments.

The time at which samples are collected is of particular importance since a single measurement can give only a limited insight into the overall exposure profile and it is generally more informative to use multiple time points when one wishes to characterise absorption and elimination behaviour.

The way in which pharmacokinetic results are interpreted also involves analytical specificity. For instance, measuring the total immunoreactive material is not always the same as measuring the intact parent peptide, since degradation products or other related molecular species may add to the analytical signal.

That is why peptide identity and the analytical method used should be taken into account together with the pharmacokinetic data, rather than regard the concentration measurements as conclusive proof of intact peptide transport.

Formulation Variables in Intranasal Peptide Research

The development of intranasal peptide formulations is a field of multidisciplinary research that draws together peptide chemistry, pharmaceutical science, and nasal physiology.

Variables such as pH, osmolality, solubility, viscosity, peptide concentration, excipient selection and physical deposition can influence the behaviour of a formulation. Research has also examined permeation enhancers, mucoadhesive materials, nanoparticles and other delivery systems.

It is especially important to enhance permeability since the nasal epithelium is a biological barrier and not an unobstructed absorption surface. Certain experimental methods aim either to temporarily change the permeability of the epithelium or to increase the length of time that peptides remain there.

Each of these methods has to be assessed separately for every formulation, and it cannot be taken for granted that a formulation strategy which alters the absorption of one peptide will have the same effect on another sequence or molecular structure.

The peptide itself and the delivery system should therefore be considered as separate experimental variables when it comes to research interpretation.

Experimental Models Used in Intranasal Peptide Research

Intranasal peptide research uses several experimental models, including cell-based epithelial systems, isolated tissues, animal models and controlled pharmacokinetic studies.

Cell-based systems are useful for investigating epithelial permeability and molecular transport under controlled conditions, and they can be employed to study barrier function, though they do not replicate all the features of an intact nasal cavity.

Animal models provide additional information about deposition, absorption, metabolism and tissue distribution. However, nasal anatomy differs between species, meaning that results from one model cannot automatically be translated to another.

Human pharmacokinetic research provides another level of evidence but remains dependent on the exact peptide, formulation, analytical method and study design.

It is important to take these distinctions into account when assessing research literature, since a finding obtained from an epithelial cell model is a different kind of evidence from one that results from a measurement of intact peptide in a human pharmacokinetic study.

Analytical Considerations for Peptide Nasal Research

It is necessary to carry out reliable analytical identification when assessing peptide delivery.

High-performance liquid chromatography is suitable for determining chromatographic purity, and mass spectrometry can be used for molecular identification and for telling the related species apart. However, further analytical methods might be necessary according to the peptide in question and the experimental objective.

The analytical method had to correspond with the research question; in the case where the aim is to find out if any intact peptide remains, one that is able to tell the parent compound apart from the degradation products becomes particularly relevant.

Batch identity is just as important when it comes to research materials since the value of a scientific conclusion depends on the material that is being tested; variations in purity, sequence, modification state or degradation could introduce variability which might otherwise be assigned to biological effects.

Limitations of Current Intranasal Peptide Research

The research into intranasal peptide delivery is still ongoing and it is not yet a universally applicable method for delivering peptides.

One major limitation is variability in nasal absorption. Peptide properties, formulation, epithelial condition, mucociliary clearance and deposition can all influence experimental results.

A further limitation is the fact that it is difficult to distinguish between systemic exposure and direct transport to the central nervous system. The fact that peptide-derived material has been found in brain tissue does not mean that the pathway by which it got there has been established.

The need for careful interpretation applies to animal studies since the nasal anatomy and physiology differ from species to species and as a result the findings from rodents or other experimental models might offer some information about mechanisms without showing how the same peptide would act in a different biological system.

It would be wrong to apply evidence obtained for one peptide to all compounds in a given category. The sequence, molecular structure, the formulation and the analytical methodology can all considerably affect the results of experiments.

Research Use Only

The peptide materials referred to in this article are described within a research and laboratory setting, and the purpose of the article is to explain the scientific ideas concerning nasal mucosal biology, peptide stability, permeability and pharmacokinetic research.

It doesn't include any instructions regarding administration to humans or animals, nor does it cover dosing, treatment, disease management, or therapeutic use.

When assessing research materials, one should consider their stated chemical identity, the analytical data, their purity, and the testing that has been carried out specifically for each batch, rather than relying on claims regarding human outcomes.

FAQs